I"Ú!<h1 class="post-title" itemprop="name headline">Applications</h1>
<p>This page shows some of the applications of the collected riboswitches. We listed four kinds of applications, ‚ÄòDeveloping new antibacterials‚Äô, ‚ÄòSynthetic Biology‚Äô, ‚ÄòBuilding biosensors‚Äô and ‚ÄòGene therapy‚Äô as shown in the following tables. The representatives of FMN riboswitch-specific antibacterial compounds are presented, as shown in the figure below.
<br /><br /></p>
<html>
<head>
  <title>Ê®™ÂêëÊéíÂàóÁöÑÁÇπÂáªÊåâÈíÆ</title>
  
</head>
<body>
<p id="Developing_new_antibacterials"> </p>
  <p style="font-size: 16px">Click into different sections:</p>
  <div class="button-container">
    <a class="button" href="#Developing_new_antibacterials">Developing new antibacterials</a>
    <a class="button" href="#Synthetic_Biology">Synthetic Biology</a>
    <a class="button" href="#Building_biosensors">Building biosensors</a>
    <a class="button" href="#Gene_therapy">Gene therapy</a>
  </div>
</body>
</html>
<p><br /></p>

<p class="header_box">Developing new antibacterials</p>
<p>Riboswitches can affect bacterial homeostasis, development, pathogenicity, and antibiotic resistance at the transcriptional or translational level and generate complex three-dimensional structures with well-defined small-molecule binding sites. These features make them attractive targets for antimicrobial therapy.<br /></p>

<p>Schematic representation of the FMN riboswitch as new antibacterials target. Different antibacterial compounds bind to the FMN riboswitch and abolish the expression of the downstream genes (left). The chemical structure and KD of the antibacterial compounds is also indicated (right).<br />
<img src="/images/applications/application_figure.svg" alt="drawing" style="weight:400px;display:block;margin:0 auto;border:solid 1px;border-radius:0;" /><br />
<a href="/images/applications/application_figure.svg" target="_blank" download="Developing new antibacterials.svg"><button class="btn btn-secondary"><span class="glyphicon  glyphicon-download-alt"></span>¬†¬†Download above picture</button></a><br />
<br /></p>

<html>
<head>
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width,initial-scale=1,user-scalable=no" />
    <title>Ribozyme applications </title>
    <link rel="stylesheet" type="text/css" href="https://cdn.datatables.net/1.12.1/css/jquery.dataTables.min.css" />
    <link rel="stylesheet" type="text/css" href="https://cdn.datatables.net/buttons/2.2.3/css/buttons.dataTables.min.css" />
</head>
    <style>
        th {background-color: #005826;
        color: rgba(255,255,255,0.9);
            cursor: pointer;
        }
    </style>
  <script type="text/javascript" src="https://code.jquery.com/jquery-3.5.1.js"></script>
    <script type="text/javascript" src="https://cdn.datatables.net/1.12.1/js/jquery.dataTables.min.js"></script>
    <script type="text/javascript" src="https://cdn.datatables.net/buttons/2.2.3/js/dataTables.buttons.min.js"></script>
    <script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.1.3/jszip.min.js"></script>
    <script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.1.53/pdfmake.min.js"></script>
    <script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.1.53/vfs_fonts.js"></script>
    <script type="text/javascript" src="https://cdn.datatables.net/buttons/2.2.3/js/buttons.html5.min.js"></script>
    <script type="text/javascript" src="https://cdn.datatables.net/buttons/2.2.3/js/buttons.print.min.js"></script>
    <script type="text/javascript">

        $(document).ready(function() {
            $.noConflict();
            $('#Dnatable').DataTable( {
                dom: 'Bfrtip', 
                buttons: [
                    'copy', 'csv', 'excel', 'pdf', 'print'
                ]

            } );
        } );
   </script>
<table id="Dnatable" class="table table-striped table-bordered" cellspacing="0" width="100%">
  <thead>
  <tr>
    <th>Riboswitch name</th>
    <th>Description </th>
    <th>First author</th>
    <th>Corresponding author</th>
    <th>Time</th>
    <th>reference</th>
    <th>Journal</th>
  </tr>
 </thead>
 <tbody>
        
  <tr>
    <td><a href="https://ribocentre-switch.github.io/docs/TPP" target="_blank"><b>TPP riboswitch</b></a></td>
    <td>This paper provided validation that TPP riboswitches are antimicrobial drug targets, and indicated that antimicrobial compounds known for decades function at least in part by a riboswitch-related mechanism. </td>
    <td>Narasimhan Sudarsan</td>
    <td>Ronald R. Breaker</td>
    <td>2005</td>
    <td>Thiamine Pyrophosphate Riboswitches Are Targets for the Antimicrobial Compound Pyrithiamine</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/16356850" target="_blank"><b>Chemistry &amp; Biology</b></a></td>
  </tr>
    
                    
  <tr>
    <td><a href="https://ribocentre-switch.github.io/docs/FMN" target="_blank"><b>FMN riboswitch</b></a></td>
    <td>This paper identified a novel series of flavin analogs that are potent and highly selective C. difficile antibacterial compounds. Among them,5FDQD could prevent lethal CDI in mice without disrupting the regrowth of beneficial flora.</td>
    <td>Kenneth F. Blount</td>
    <td>Ronald R. Breaker</td>
    <td>2015</td>
    <td>Novel Riboswitch-Binding Flavin Analog That Protects Mice against Clostridium difficile Infection without Inhibiting Cecal Flora</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/26169403" target="_blank"><b>Antimicrobial Agents and Chemotherapy</b></a></td>
  </tr>
    
                    
  <tr>
    <td><a href="https://ribocentre-switch.github.io/docs/FMN" target="_blank"><b>FMN riboswitch</b></a></td>
    <td>In this paper, a series of riboflavin derivatives were designed, synthesized and screened for their antibacterial activity. Some of these compounds showed significant anti-tuberculosis activity against Mycobacterium tuberculosis.</td>
    <td>Bhaiyyasaheb Harale</td>
    <td>Ambadas B. Rode</td>
    <td>2021</td>
    <td>Synthesis and Evaluation of Antimycobacterial Activity of Riboflavin Derivatives</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/34242760" target="_blank"><b>Bioorganic &amp; Medicinal Chemistry Letters </b></a></td>
  </tr>
    
                    
  <tr>
    <td><a href="https://ribocentre-switch.github.io/docs/FMN" target="_blank"><b>FMN riboswitch</b></a></td>
    <td>This paper reported a phenotypic screen and the discovery of ribocil, a highly specific bioactive synthetic mimic of FMN, which competed with the natural ligand to inhibit FMN riboswitch-mediated expression of ribB and inhibited bacterial growth.</td>
    <td>John A. Howe</td>
    <td>Terry Roemer</td>
    <td>2015</td>
    <td>Selective Small-Molecule Inhibition of an RNA Structural Element</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/26416753" target="_blank"><b>Nature</b></a></td>
  </tr>
    
                    
  <tr>
    <td><a href="https://ribocentre-switch.github.io/docs/FMN" target="_blank"><b>FMN riboswitch</b></a></td>
    <td>This paper reports a new co-crystal structure of the F. nucleatum FMN aptamer in complex with ribocil-D, a close analog of ribocil, which reaffirms the previously described binding mode of ribocil to the FMN aptamer.</td>
    <td>John A. Howe</td>
    <td>Terry Roemer</td>
    <td>2016</td>
    <td>Atomic resolution mechanistic studies of ribocil: A highly selective unnatural ligand mimic of the E. coli FMN riboswitch</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/27485612" target="_blank"><b>RNA Biology </b></a></td>
  </tr>
    
                    
  <tr>
    <td><a href="https://ribocentre-switch.github.io/docs/FMN" target="_blank"><b>FMN riboswitch</b></a></td>
    <td>This paper investigated the effects of riboflavin and its analogue roseflavin on bacterial growth and expression of FMN nucleoprotein switch genes in Listeria monocytogenes.And found that Roseoflavin could inhibit bacterial growth and the expression of the gene located downstream of the target riboswitch in both minimal medium and in rich medium.</td>
    <td>Mikael Mansj√∂</td>
    <td>J√∂rgen Johansson</td>
    <td>2011</td>
    <td>The Riboflavin Analog Roseoflavin Targets an FMN-Riboswitch and Blocks Listeria Monocytogenes Growth, but Also Stimulates Virulence Gene-Expression and Infection</td>
    <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/21593602" target="_blank"><b>RNA Biology </b></a></td>
  </tr>   
                    
</tbody>
</table>
</html>
<p><br /></p>

:ET